Associate Professor, Urology, University of Texas Southwestern Medical Center, Southwestern Medical School
Urology
Dr. Ganesh V. Raj, MD
|
|
Give Review
Ganesh is an expert in the field of Urology. He went to Jefferson Medical College. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Ganesh V. Raj has written publications. He has 90 publications published with PubMed. The lastest publication is: 'T-antigen-dependent transcriptional initiation and its role in the regulation of human neurotropic JC virus late gene expression.' He is registered with Medicare.
Publications
- Do Referral Patterns in Adolescents and Young Adults with Testicular Cancer Impact Oncologic Outcomes?
- The Utility of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance.
- Expression of androgen receptor splice variants in clinical breast Cancers.
- Association of distance to treatment facility on quality and survival outcomes after radical cystectomy for Bladder cancer.
- Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast Cancer cells.
- NFI Transcription Factors Interact with FOXA1 to Regulate Prostate-Specific Gene Expression.
- The social network of PELP1 and its implications in breast and prostate Cancer.
- Risk stratification of pubertal children and postpubertal adolescents with clinical stage I Testicular nonseminomatous germ cell tumors.
- Emerging therapies in castration resistant prostate Cancer.
- Tailoring Peptidomimetics for Targeting Protein-protein Interactions.
- Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate Cancer.
- Progesterone receptor-B enhances estrogen responsiveness of breast Cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.
- Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: Results of a current series and a revie...
- Emerging drugs for prostate Cancer.
- A comparison of pediatric, adolescent, and adult Testicular germ cell malignancy.
- Prospective comparison of molecular signatures in urothelial cancer of the Bladder and the upper urinary tract: is there evidence for discordant biology?
- The dilemma of a rising Prostate-specific antigen level after local therapy: what are our options?
- Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate Cancer.
- Prospective Evaluation of a Molecular Marker Panel for Prediction of Recurrence and Cancer-specific Survival After Radical Cystectomy.
- Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary Bladder: can post-induction random Bladder biopsies be avoided?
- Renal Oxygenation During Partial Nephrectomy: A Comparison Between Artery-Only Occlusion Versus Artery and Vein Occlusion.
- Reduction in Hospital Admission Rates Due to Post-Prostate Biopsy Infections After Augmenting Standard Antibiotic Prophylaxis.
- Effect of Testicular Germ Cell Tumor Therapy on Renal Function.
- A validated tumorgraft model reveals activity of dovitinib against Renal cell carcinoma.
- Management of biochemical recurrence after primary localized therapy for prostate Cancer.
- Central Role for PELP1 in Nonandrogenic Activation of the Androgen Receptor in Prostate Cancer.
- Significance of PELP1 in ER-Negative Breast Cancer Metastasis.
- Assessment of Renal oxygenation during partial nephrectomy using hyperspectral imaging.
- Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms Tumor.
- Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal Prostate epithelial cell line.
- Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive Bladder cancer.
- Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate Cancer cells.
- Growing teratoma syndrome.
- The screening for Occult Renal Disease (SCORED) value is associated with a higher risk for having or developing Chronic kidney disease in patients treated for small, u...
- Preoperative nomogram predicting 12-year probability of metastatic renal Cancer.
- How to build and interpret a nomogram for Cancer prognosis.
- Renal function outcomes in patients treated for Renal masses smaller than 4 cm by ablative and extirpative techniques.
- Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial Cancer and the potential implications for long-term surveillance.
- Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small Renal cell carcinoma.
- Rectourethral fistula after combination radiotherapy for prostate Cancer.
- Treatment paradigm shift may improve survival of patients with high risk superficial Bladder cancer.
- Radical cystectomy and lymphadenectomy for invasive Bladder cancer: towards the evolution of an optimal surgical standard.
- Predicting the histology of Renal masses using preoperative Doppler ultrasonography.
- Incidence of benign lesions for clinically localized Renal masses smaller than 7 cm in radiological diameter: influence of sex.
- Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial Cancer.
- Natural history of positive Urinary cytology after radical cystectomy.
- Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in Bladder cancer.
- Association between Urinary cytology and pathology for nontransitional cell malignancies of the Urinary tract.
- Outcomes following erosions of the artificial Urinary sphincter.
- Complications after percutaneous radiofrequency ablation of Renal tumors.
- Anterior rectal wall gastrointestinal stromal tumor presenting clinically as prostatic mass.
- Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model.
- Outcomes following revisions and secondary implantation of the artificial Urinary sphincter.
- Anastomotic contracture and incontinence after radical Prostatectomy: a graded approach to management.
- Does prior benign Prostate biopsy predict outcome for patients treated with radical perineal Prostatectomy?
- Lysophosphatidic acid promotes survival of androgen-insensitive prostate Cancer PC3 cells via activation of NF-kappaB.
- Metabolic abnormalities associated with renal calculi in patients with horseshoe Kidneys.
- Ureteral access sheath provides protection against Elevated renal pressures during routine flexible ureteroscopic stone manipulation.
- Percutaneous management of calculi within horseshoe Kidneys.
- Autoimmune Testicular vasculitis.
- Liposarcoma presenting as an intraluminal Ureteral mass.
- Management of small Renal tumors with radiofrequency ablation.
- Laser Doppler flowmetric determination of ureteral Blood flow after ureteral access sheath placement.
- Guanosine phosphate binding protein coupled receptors in prostate Cancer: a review.
- Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent Prostate carcinoma after radical Prostatectomy.
- Long-term oral anticoagulant therapy: update on indications, therapeutic ranges, and monitoring.
- T-Antigen-dependent transcriptional initiation and its role in the regulation of human neurotropic JC virus late gene expression.
- Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy.
- Perioperative prophylaxis of venous thromboembolism.
- Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione.
- Adverse cardiac events after surgery: assessing risk in a veteran population.
- Multimodal therapy for stage IV adult Wilms tumor.
- Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate Cancer.
- Utilization of polymerase chain reaction technology in the detection of solid tumors.
- Sirolimus and temsirolimus for epithelioid angiomyolipoma.
- Determining the incidence of horseshoe Kidney from radiographic data at a single institution.
- The incidence of nephrolithiasis in patients with spinal neural tube defects.
- Management of small Renal tumors: an overview.
- Defining early morbidity of radical cystectomy for patients with Bladder cancer using a standardized reporting methodology.
- Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.
- Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial Cancer.
- Malignant cystic nephroma.
- Outcomes of patients with clinical T1 grade 3 urothelial cell Bladder carcinoma treated with radical cystectomy.
- Predictive value of the differential expression of the urokinase plasminogen activation axis in radical Prostatectomy patients.
- Radiofrequency ablation of small Renal cortical tumours in healthy adults: Renal function preservation and intermediate oncological outcome.
- Management of elderly patients with urothelial carcinoma of the Bladder: guideline concordance and predictors of overall survival.
- Renal functional outcomes for tumours in a solitary Kidney managed by ablative or extirpative techniques.
- The impact of targeted molecular therapies on the level of Renal cell carcinoma vena caval tumor thrombus.
- Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC.
Schools
Thomas Jefferson University
Procedures Preformed
- AdRenalectomy
- Cystectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Semen (Hematospermia)
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Assurant Health
- Blue Card PPO
- Blue Choice
- CHAMPVA
- Cigna HMO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Commercial Insurance Company
- CoreSource
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- HealthFirst
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- Molina
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Duke University Hospital -
Jefferson Medical College
Hospital
-
University of Texas Southwestern Medical Center -
Veterans Affairs North Texas Health Care System
Drug Facts
| NPI NUMBER | 1790882488 | |
| NPPES Provider LastName | RAJ | |
| NPPES Provider FirstName | GANESH | |
| NPPES Provider ZIPCode | 753907208 | |
| NPPES Provider State | TX | |
| Specialty Description | Urology | |
| Total Claim Count | 324.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 20.0 | |
| Percent Opioid Claims | 6.17 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790882488 |
| Last Name Of The Provider | RAJ |
| First Name Of The Provider | GANESH |
| View All |
Similar Doctors
|
Dr. Pat F. Fulgham, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey C. Toubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric B. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George P. Shropulos, MD |
|
|
Dr. Philippe E. Zimmern, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward P. Kaplan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nakizito N. Kazigo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Belsante, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew A. Meissner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan J. Mauck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Casey A. Seideman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Jacqueline D. Smith, MS
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Ramirez, MD |